DexCom, Inc.
NASDAQ: DXCM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jacob Steven Leach
- Employees
- 10,200
- Headquarters
- San Diego, United States
- IPO year
- 2005
- Market cap
- $28.0B
- Website
- https://www.dexcom.com
Loading DXCM…
Loading profile data…Frequently asked questions about DXCM
What does DexCom, Inc. (DXCM) do?
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the...
Where does DXCM trade?
DexCom, Inc. (DXCM) trades on the NASDAQ Global Select.
What sector is DXCM in?
DexCom, Inc. (DXCM) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of DexCom, Inc.?
Jacob Steven Leach is the chief executive officer of DexCom, Inc. (DXCM).
Where is DexCom, Inc. headquartered?
DexCom, Inc. is headquartered in United States.
Does DXCM pay a dividend?
DexCom, Inc. (DXCM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DXCM go public?
DexCom, Inc. (DXCM) completed its initial public offering in 2005.